Dynamic Diabetes Solutions: Physiologic Insulin Resensitization
Brian Loveridge, Tori Tucker, Melanie St. Laurent, Scott Hepford, Michael Alexander, Jonathan RT Lakey
Diabetes is a disease currently affecting over 30 million Americans and is a leading cause of amputation, blindness, and chronic kidney disease. Treatment of diabetes with medications and lifestyle modifications alone have not eliminated these complications, because in part they lack the ability to restore the periodic cycles and rest periods of insulin that exist in healthy physiology. Insulin is excreted in a cyclical pattern by the pancreas, in a hormonal oscillation that is critical to maintain adequate insulin sensitivity at the insulin receptor level. Precision administration of exogenous insulin bio identically matching this physiologic profile is more effective at controlling blood glucose level and reducing complications of diabetes than standard drug therapy and lifestyle modifications alone. This matching of physiological insulin helps reduce inflammatory cascades responsible for a number of diabetic complications. In this article, we will review how insulin is secreted and functions physiologically and highlight a dynamic insulin delivery modality that mimics normal secretion profiles. This biomimicry reduces insulin exposure, which reduces the progression to or worsening of insulin resistance. We will review how various protocols have been enhanced resulting in reduction of diabetic complications, utilizing physiologic insulin resensitization (PIR).
View pdf